RACHEL DEGTYAREV: Open Payments
NPI 1205371770 · CAMDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$137 in 7 payments from 7 companies in 2025. Trend: 2023 $548 · 2024 $270 · 2025 $137
Food & beverage: $137
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| Ascendis Pharma Endocrinology Inc | 1 | $23 |
| Exact Sciences Corporation | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Seqirus USA Inc | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Novo Nordisk Inc | 1 | $15 |
Products named: Yorvipath, Cologuard Collection Kit, GEMTESA, Flucelvax, AIRSUPRA, Wegovy.
Industry payments across NJ — which companies pay providers there.
